Attendees of the 3-day conference, including patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists, will leave with knowledge of:
- Accelerating drug development across neurology, rare diseases, pediatrics, and beyond.
- Integrating insights across therapeutic areas to advance the process for novel treatments and cures.
- The power of every precious data point in rare and orphan diseases.
- Navigating novel therapies with novel evidence sources.
- Innovative methods and approaches.
- The value and impact that C-Path partnerships have on accelerating drug development.
Agenda
Speakers
C-Path